Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

CHRSCHRS
23 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in COHERUS ONCOLOGY INC

Bank of New York Mellon Corp holds 319,687 shares of CHRS (COHERUS ONCOLOGY INC), worth $447,563 as of 2026-Q2. The position was increased (+12.2% shares). CHRS represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$447,563

Current Shares

319,687

Total Value Change

-$13.9M

Total Shares Change

-504,549

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
319,687
+12.2%
$447,5630.0%$1.40
27
2026-Q1
Decreased
285,033
-2.0%
$481,7060.0%$1.65
0
2025-Q4
Decreased
290,863
-22.8%
$413,0250.0%$1.41
0
2025-Q3
Decreased
376,685
-3.5%
$617,7630.0%$1.70
0
2025-Q2
Increased
390,313
+0.3%
$285,4350.0%$0.74
23
2025-Q1
Decreased
389,121
-0.5%
$314,0200.0%$0.84
0
2024-Q4
Increased
391,002
+26.6%
$539,5820.0%$1.50
30
2024-Q3
Decreased
308,780
-20.7%
$321,1310.0%$1.05
0
2024-Q2
Increased
389,225
+26.0%
$673,3590.0%$1.73
30
2024-Q1
Decreased
309,003
-12.8%
$738,5170.0%$2.39
0
2023-Q4
Decreased
354,271
-10.4%
$1.2M0.0%$3.33
0
2023-Q3
Decreased
395,527
-33.0%
$1.5M0.0%$3.74
0
2023-Q2
Increased
590,048
+5.2%
$2.5M0.0%$4.19
28
2023-Q1
Decreased
560,900
-3.2%
$3.8M0.0%$6.43
0
2022-Q4
Decreased
579,408
-7.1%
$4.6M0.0%$7.92
0
2022-Q3
Increased
623,891
+7.7%
$6M0.0%$9.35
29
2022-Q2
Decreased
579,311
-3.0%
$4.2M0.0%$7.40
0
2022-Q1
Decreased
597,045
-15.8%
$7.7M0.0%$12.84
0
2021-Q4
Decreased
709,284
-12.9%
$11.3M0.0%$16.74
0
2021-Q3
Increased
814,371
+2.9%
$13.1M0.0%$16.46
29
2021-Q2
Decreased
791,099
-4.6%
$10.9M0.0%$14.04
0
2021-Q1
Increased
829,625
+0.7%
$12.1M0.0%$14.45
28
2020-Q4
New
824,236
-
$14.3M0.0%$17.57
39

Other major holders of CHRS: BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used